Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Montreal Heart Institute
With
Johnson & Johnson
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Groups 1 and 2
Age \>18 years
Group 1: hemoglobin \< 120g/L in women and \< 130 g/L in men (in agreement with the WHO definition of anemia)
Group 2: hemoglobin \> or = 120g/L in women and \> or = 130 g/L in men
Patients with chronic HF referred to a specialized HF clinic, or with a diagnosis of HF at least 6 months prior to enrolment
NYHA functional class II-IV at the time of enrolment
Patients already on CHF medical therapy (ACEI or ARBs, beta-blockers if tolerated, with or without digoxin, and loop diuretics), at stable doses for \> or = 1 month
LVEF \< or = 40% within 6 months prior to patient enrolment, by echocardiography, radionuclide ventriculography or perfusion scan, or radiologic angiography
Age \>18 years
At least moderate CRF (eGFR \< 60ml/min/1,73m2)
With or without anemia
LVEF \> or = 50% within 6 months prior to patient enrolment, by echocardiography, radionuclide ventriculography or perfusion scan, or radiologic angiography
You may not be if
Recent acute renal failure episode (\< 1 month)
Red blood cells (or other blood component) transfusions or EPO therapy within 3 months prior to enrolment
Iron, B12 or folic acid supplements used to treat anemia (\< 3 months)
